DE60134740D1 - Zusammensetzung zur potenzierung von krebs-chemotherapeutika - Google Patents
Zusammensetzung zur potenzierung von krebs-chemotherapeutikaInfo
- Publication number
- DE60134740D1 DE60134740D1 DE60134740T DE60134740T DE60134740D1 DE 60134740 D1 DE60134740 D1 DE 60134740D1 DE 60134740 T DE60134740 T DE 60134740T DE 60134740 T DE60134740 T DE 60134740T DE 60134740 D1 DE60134740 D1 DE 60134740D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- cancer chemotherapeutic
- potentiating
- potentiating cancer
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000000973 chemotherapeutic effect Effects 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 abstract 1
- 150000000994 L-ascorbates Chemical class 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002241 furanones Chemical class 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 150000003700 vitamin C derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/654,377 US6468980B1 (en) | 2000-09-01 | 2000-09-01 | Methods and compositions for potentiating cancer chemotherapeutic agents |
| PCT/US2001/026455 WO2002020023A1 (en) | 2000-09-01 | 2001-08-24 | Methods and compositions for potentiating cancer chemotherapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60134740D1 true DE60134740D1 (de) | 2008-08-21 |
Family
ID=24624611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60134740T Expired - Lifetime DE60134740D1 (de) | 2000-09-01 | 2001-08-24 | Zusammensetzung zur potenzierung von krebs-chemotherapeutika |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6468980B1 (de) |
| EP (1) | EP1286674B1 (de) |
| JP (1) | JP2004508335A (de) |
| KR (1) | KR20030019297A (de) |
| AT (1) | ATE400267T1 (de) |
| AU (1) | AU8525401A (de) |
| CA (1) | CA2389602A1 (de) |
| CY (1) | CY1108787T1 (de) |
| DE (1) | DE60134740D1 (de) |
| DK (1) | DK1286674T3 (de) |
| ES (1) | ES2309085T3 (de) |
| MX (1) | MXPA02004327A (de) |
| PT (1) | PT1286674E (de) |
| TR (1) | TR200201192T1 (de) |
| WO (1) | WO2002020023A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878744B2 (en) * | 1999-02-05 | 2005-04-12 | Oxycal Laboratories, Inc. | Vitamin C compositions |
| CN1197561C (zh) * | 2001-07-03 | 2005-04-20 | 北京巨能亚太生命科学研究中心 | L－苏糖酸钙在制备预防或治疗损及软骨的疾病的药物中的用途 |
| DE60329536D1 (de) | 2003-08-13 | 2009-11-12 | Ester C Company | Verfahren zur linderung von umweltbedingtem stress durch oxidationsmittel und regulierung vorteilhafter gene |
| EP3542785A1 (de) * | 2007-01-31 | 2019-09-25 | Rutgers, The State University of New Jersey | Gesteuerte freisetzung von wirkstoffen in der haut |
| KR101998246B1 (ko) * | 2018-08-22 | 2019-07-10 | 주식회사 메타파인즈 | 금속이온에 결합된 이온화합물을 포함하는 암 치료용 약학 조성물 |
| TR2022000209A2 (tr) | 2022-01-07 | 2022-02-21 | Oezge Gueven | Ozoni̇ze c-vi̇tami̇ni̇ i̇çeren bi̇r anti̇-kanser i̇laci |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987003481A1 (en) * | 1985-12-05 | 1987-06-18 | American Biotechnology Co., Ltd. | Anthracycline type antitumor agents with l-ascorbic acid |
| GB8810173D0 (en) * | 1988-04-29 | 1988-06-02 | Norsk Hydro As | Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer |
| WO1990012571A1 (en) * | 1989-04-07 | 1990-11-01 | Oxycal Laboratories, Inc. | Compositions and methods for administering vitamin c |
| JPH08291075A (ja) * | 1995-04-20 | 1996-11-05 | Showa Denko Kk | 癌転移阻害剤 |
| EP0875246A1 (de) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs |
| ATE341938T1 (de) * | 1998-02-06 | 2006-11-15 | Zila Nutraceuticals Inc | Stabile flüssige zusammensetzungen von kalzium- ascorbat und verfahren zu ihrer herstellung und verwendung |
| CN1165301C (zh) * | 1999-08-30 | 2004-09-08 | 奥克斯可尔实验室公司 | 组合物在制备治疗癌症的药物中的用途 |
-
2000
- 2000-09-01 US US09/654,377 patent/US6468980B1/en not_active Expired - Lifetime
-
2001
- 2001-08-24 KR KR1020027005605A patent/KR20030019297A/ko not_active Ceased
- 2001-08-24 JP JP2002524507A patent/JP2004508335A/ja active Pending
- 2001-08-24 CA CA002389602A patent/CA2389602A1/en not_active Abandoned
- 2001-08-24 DK DK01964398T patent/DK1286674T3/da active
- 2001-08-24 AT AT01964398T patent/ATE400267T1/de not_active IP Right Cessation
- 2001-08-24 ES ES01964398T patent/ES2309085T3/es not_active Expired - Lifetime
- 2001-08-24 TR TR2002/01192T patent/TR200201192T1/xx unknown
- 2001-08-24 EP EP01964398A patent/EP1286674B1/de not_active Expired - Lifetime
- 2001-08-24 MX MXPA02004327A patent/MXPA02004327A/es active IP Right Grant
- 2001-08-24 PT PT01964398T patent/PT1286674E/pt unknown
- 2001-08-24 DE DE60134740T patent/DE60134740D1/de not_active Expired - Lifetime
- 2001-08-24 AU AU85254/01A patent/AU8525401A/en not_active Abandoned
- 2001-08-24 WO PCT/US2001/026455 patent/WO2002020023A1/en not_active Ceased
-
2008
- 2008-09-23 CY CY20081101028T patent/CY1108787T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2389602A1 (en) | 2002-03-14 |
| DK1286674T3 (da) | 2008-11-03 |
| WO2002020023A1 (en) | 2002-03-14 |
| ES2309085T3 (es) | 2008-12-16 |
| TR200201192T1 (tr) | 2003-05-21 |
| AU8525401A (en) | 2002-03-22 |
| EP1286674A1 (de) | 2003-03-05 |
| MXPA02004327A (es) | 2002-11-07 |
| KR20030019297A (ko) | 2003-03-06 |
| ATE400267T1 (de) | 2008-07-15 |
| EP1286674B1 (de) | 2008-07-09 |
| EP1286674A4 (de) | 2005-12-21 |
| US6468980B1 (en) | 2002-10-22 |
| JP2004508335A (ja) | 2004-03-18 |
| PT1286674E (pt) | 2008-08-21 |
| CY1108787T1 (el) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113798A (pt) | Derivados de resorcinol | |
| TR200000782T2 (tr) | Resorsinol türevleri. | |
| AU2795000A (en) | Epothilone derivatives and their use as antitumor agents | |
| PT960107E (pt) | Compostos de paclitaxel 6-tio-substituidos | |
| MXPA03007140A (es) | Derivados de carbolina. | |
| ATE387435T1 (de) | Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren | |
| MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
| PL363168A1 (pl) | Cyklopentanole, kompozycje zawierające takie związki i sposoby leczenia | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| BR9912327A (pt) | Inibidores da uroquinase | |
| CY1108787T1 (el) | Συνθεση για ενισχυση χημειοθεραπευτικων παραγοντων καρκινου | |
| EA200200808A1 (ru) | Модифицированные цитокины, предназначенные для применения в терапии рака | |
| BR0114379A (pt) | Derivados de c-ciclohexilmetilamina substituìdos | |
| TR200102742T2 (tr) | Rezorsinol türevleri | |
| IL138688A0 (en) | Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme | |
| ATE259813T1 (de) | Triazolopyrimidinderivate | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
| DE60026350D1 (de) | Diaryl piperidyl-pyrrol-derivate als antiprotozoenmittel | |
| TR200302134T4 (tr) | 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. | |
| PT981358E (pt) | Derivados de dolastatina-15 em combinacao com taxanos | |
| TR200302193T4 (tr) | Kombinasyon kemoterapisi. | |
| BR0208221A (pt) | Combinação de uma taxano e uma cinase dependente de ciclina | |
| DE60111614D1 (de) | Taxan-derivate für die behandlung von krebs | |
| DE60134814D1 (de) | C10-carbamoyloxysubstituierte taxane als antitumormittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |